SCHEMBL5084422

SCHEMBL5084422

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3c(-c4cc5ccc6cccc7ccc(c4)c5c67)cccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.43
ERBB2 P04626 1/20 0.43
FYN P06241 1/20 0.43
MAOA P21397 1/20 0.43
ACHE P22303 1/20 0.43
AHR P35869 1/20 0.43
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
ALDH1A1 P00352 6/20 0.38
HSD17B10 Q99714 5/20 0.38
HPGD P15428 5/20 0.38
THRB P10828 1/20 0.38
CES1 P23141 1/20 0.38
CDK4 P11802 2/20 0.37
CCND1 P24385 2/20 0.37
TSHR P16473 4/20 0.36
MAPK1 P28482 3/20 0.36
CASP1 P29466 2/20 0.36
HIF1A Q16665 2/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5084434 0.89 CYP1A2 (0.42) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL5078461 0.84 CYP1A2 (0.43) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL27949362 0.84 HSD17B1 (0.42) CYP1A2ESR1ESR2ALDH1A1HSD17B10
SCHEMBL5599120 0.80 ACHE (0.42) CYP1A2ACHEESR1ESR2ALDH1A1
SCHEMBL23651921 0.78 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL28725947 0.78 ESR1 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL5080664 0.78 ERBB2 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL29211542 0.77 PIM1 (0.40) CYP1A2ALDH1A1HSD17B10HPGDCDK4
SCHEMBL27697459 0.77 CYP1A2 (0.53) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL2519749 0.76 CES1 (0.59) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080299294-A1 ANTHRACENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME Yen, Feng Wen (TW) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080299294-A1 ANTHRACENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME ARL1, ARNT, AHR CYP1A2 26/4885ERBB2 2700/4885FYN 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.